Clinical and radiographic outcomes with the Nanos™ short-stem hip implant at 24 months: A prospective, single-center study.

AIM: Short-stem total hip arthroplasty is designed to preserve proximal bone stock in case of eventual revision, potentially benefiting younger and more active patients. This prospective, single-center study assessed the safety and performance of the partially neck-sparing Nanos™ short-stem uncemented prosthesis at 24 months using clinical outcome scores and radiographic results. METHODS: Between April 2011 and February 2015, 52 subjects (mean age, 54.9 years) underwent total hip arthroplasty and were followed up at 3, 6, 12 and 24 months. The primary outcome was improvement in quality of life as measured by the Short-Form 36 Mental Component Score (SF-36 MCS). Secondary clinical outcomes included the Harris Hip Score, Hip Disability and Osteoarthritis Outcome Score, Postel Merle d'Aubigné-Score, Activity Level University of California, Los Angeles score, and Pain Visual Analogue Scale. Complications and radiographic images were also recorded at each follow-up. RESULTS: Mean SF-36 MCS score significantly improved from baseline to final follow up at 24 months (61.3 vs. 79.5, respectively; p < 0.001). All secondary clinical outcomes also showed significant improvement (p < 0.001) during this time period. Neutral stem positioning was achieved in 45 subjects (86.5%). Two subjects (3.8%) underwent revisions: one for a periprosthetic fracture unrelated to the study device and another due to a prosthetic joint infection. Intraoperatively, one fissure fracture of the acetabulum occurred. CONCLUSION: Total hip arthroplasty with the Nanos short-stem led to significant clinical improvements and a high subjective satisfaction rate at 24 months. Further follow-up will determine whether these effects are sustained in the long term.